APGE Exercise Disclosure
Dambkowski Carl · SEC Form 4 · Filed Aug 7, 2026
Exercise
Calculated transaction value
$0
Dambkowski Carl Chief Medical Officer
APGE
Apogee Therapeutics
APGE
Transaction date
Aug 5, 2026
Public filing date
Aug 8, 2026
Filing lag
Filed 3 days later
APGE daily price context
Close on/before transaction
$134.23
Aug 5, 2026
Close before public filing
$134.84
Aug 7, 2026
Return since public filing
+0.17%
Through Sep 18, 2026
Source details
- Reported owner
- Not disclosed
- Source asset code
- Derivative
- Security
- Stock Option (Right to Buy) on Common Stock
- Quantity / price
- 4,125 shares @ $0
- SEC ownership
- Direct
- Transaction code
- M
- Form
- 4
- Filing identifier
- 0001104659-26-092838
Filing cohort
Transactions in this filing
Showing 3 of 3
Trades
3
Issuers
1
Estimated value
$832.23K
Buys / sales
0 / 1
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| Apogee Therapeutics, Inc. APGE | Exercise | Aug 5, 2026 | $94.3K |
| Apogee Therapeutics, Inc. APGE | Sale | Aug 5, 2026 | $737.93K |
| Apogee Therapeutics, Inc. APGE Current | Exercise | Aug 5, 2026 | $0 |